Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/DSS.0000000000003141 | DOI Listing |
Nucleic Acids Res
September 2024
Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109, USA.
Indian J Dermatol
June 2024
From the Department of Dermatology, Ege University, Faculty of Medicine, İzmir, Turkey.
Clin Cancer Res
October 2024
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
Purpose: Deleterious germline/somatic homologous recombination repair mutations (HRRm) are present in ∼25% of patients with metastatic castration-resistant prostate cancer (mCRPC). Preclinically, poly(ADP-ribose) polymerase (PARP) inhibition demonstrated synergism with androgen receptor pathway (ARP)-targeted therapy. This trial evaluated the efficacy of ARP inhibitor versus PARP inhibitor versus their combination as first-line therapy in patients with mCRPC with HRRms.
View Article and Find Full Text PDFAnn Rheum Dis
October 2024
Division of Rheumatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Dermatopathology (Basel)
June 2024
Dermatologic Clinic, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
A 74-year-old woman in good general health presented with a 5-year history of progressive hair loss over several years, interpreted as female androgenetic alopecia (AGA), and was treated with topical 5% Minoxidil without improvement. The patient's relevant medical history revealed infiltrating, triple-negative apocrine carcinoma of the right breast four years before, treated by quadrantectomy, radiation, lymphadenectomy and chemotherapy, with no recurrence at the last follow-up. On examination, there was an asymptomatic 15 × 15 cm firm and whitish area of scarring alopecia on the central scalp.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!